|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
98,530,000 |
Market
Cap: |
18.88(M) |
Last
Volume: |
78,874 |
Avg
Vol: |
78,660 |
52
Week Range: |
$0.1916 - $0.1916 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
42,758 |
62,758 |
88,758 |
104,627 |
Total Buy Value |
$154,036 |
$241,836 |
$346,094 |
$404,389 |
Total People Bought |
5 |
5 |
5 |
5 |
Total Buy Transactions |
5 |
6 |
9 |
12 |
Total Shares Sold |
0 |
7,084 |
41,479 |
98,636 |
Total Sell Value |
$0 |
$36,199 |
$179,159 |
$193,613 |
Total People Sold |
0 |
1 |
5 |
5 |
Total Sell Transactions |
0 |
1 |
8 |
13 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Siffert Joao Md |
Chief Executive Officer |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
Tomasello Shawn |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
35,938 |
35,938 |
|
- |
|
Howell Stephen B. |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
17,969 |
97,463 |
|
- |
|
Wider Todd |
Director |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
17,969 |
192,969 |
|
- |
|
Carr Edward |
Chief Accounting Officer |
|
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
53,554 |
|
- |
|
Carr Edward |
Chief Accounting Officer |
|
2020-03-19 |
4 |
S |
$1.81 |
$11,667 |
D/D |
(6,446) |
13,554 |
|
-56% |
|
Buono Stefano |
Director |
|
2019-12-24 |
4 |
B |
$2.50 |
$500,000 |
D/D |
200,000 |
270,000 |
2.39 |
- |
|
Carr Edward |
Chief Accounting Officer |
|
2019-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
Buono Stefano |
Director |
|
2019-04-11 |
4 |
B |
$7.91 |
$387,979 |
D/D |
49,020 |
70,000 |
2.39 |
- |
|
Buono Stefano |
Director |
|
2019-04-10 |
4 |
B |
$7.54 |
$158,271 |
D/D |
20,980 |
20,980 |
2.39 |
- |
|
Van Duyne Richard B |
Director |
|
2019-04-08 |
4 |
B |
$7.71 |
$46,260 |
D/D |
6,000 |
6,000 |
2.39 |
- |
|
Howell Stephen B. |
Director |
|
2019-04-08 |
4 |
B |
$7.77 |
$31,080 |
D/D |
4,000 |
79,494 |
2.39 |
- |
|
Ahn Mark J |
Director |
|
2016-11-08 |
4 |
OE |
$2.31 |
$346,500 |
D/D |
150,000 |
493,182 |
|
- |
|
Wider Todd |
Director |
|
2016-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
Wider Todd |
Director |
|
2016-09-20 |
4 |
B |
$5.48 |
$27,400 |
D/D |
5,000 |
75,000 |
2.39 |
- |
|
Wider Todd |
Director |
|
2015-07-31 |
4 |
B |
$5.50 |
$110,000 |
D/D |
20,000 |
70,000 |
2.39 |
- |
|
Ahn Mark J |
Director |
|
2015-07-31 |
4 |
B |
$5.50 |
$100,001 |
D/D |
18,182 |
343,182 |
2.39 |
- |
|
Howell Stephen B. |
Director |
|
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
75,495 |
|
- |
|
Wider Todd |
Director |
|
2015-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Alvino Mark |
Director |
|
2015-05-11 |
4 |
A |
$7.34 |
$550,500 |
D/D |
75,000 |
75,000 |
|
- |
|
Ahn Mark J |
Director |
|
2015-05-11 |
4 |
A |
$7.34 |
$2,202,000 |
D/D |
300,000 |
325,000 |
|
- |
|
Thompson Stephen B |
Vice President Finance |
|
2015-05-11 |
4 |
A |
$7.34 |
$550,500 |
D/D |
75,000 |
84,896 |
|
- |
|
Jeffrey B Davis |
Chief Operating Officer |
|
2015-05-11 |
4 |
A |
$7.34 |
$2,202,000 |
D/D |
300,000 |
300,000 |
|
- |
|
Rouhandeh Steven H |
Executive Chairman |
|
2015-05-11 |
4 |
A |
$7.34 |
$2,752,500 |
D/D |
375,000 |
375,000 |
|
- |
|
Ahn Mark J |
Director |
|
2015-01-26 |
4 |
B |
$4.00 |
$100,000 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
156 Records found
|
|
Page 6 of 7 |
|
|